Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Kymera Therapeutics, Inc. (KYMR) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$2.76M |
|
$-82.17M |
|
-- |
|
$2.76M |
|
$95.28M |
|
$-92.52M |
|
$10.35M |
|
$-82.17M |
|
$-82.17M |
|
$-82.17M |
|
$-82.17M |
|
$-82.17M |
|
$-82.17M |
|
$-92.52M |
|
$-92.56M |
|
87.30M |
|
87.30M |
|
$-0.94 |
|
$-0.94 |
|
| Balance Sheet Financials | |
$528.30M |
|
$45.13M |
|
$573.75M |
|
$1.10B |
|
$71.58M |
|
$1.80M |
|
$84.21M |
|
$155.79M |
|
$946.26M |
|
$946.26M |
|
$946.26M |
|
71.74M |
|
| Cash Flow Statement Financials | |
$-166.14M |
|
$-126.66M |
|
$285.49M |
|
$126.05M |
|
$118.74M |
|
$-7.31M |
|
$45.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.38 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
100.00% |
|
-3347.36% |
|
-3347.36% |
|
-- |
|
-2973.05% |
|
-2973.05% |
|
$-167.49M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-8.68% |
|
-8.68% |
|
-7.46% |
|
-8.67% |
|
$13.19 |
|
$-1.92 |
|
$-1.90 |
|